CDRH Forecasts New Technological Trends, More Inter-Center Collaboration
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Science and Engineering Laboratories has revamped its research priorities and retrained staff to focus on improving both premarket and postmarket programs and regulatory science across CDRH